Keyword: Bausch & Lomb

News

Abbott to Buy OptiMedica, Strengthens Medical Device Focus

16.07.2013 - Abbott said on Monday that it would enter the laser cataract surgery business by buying privately held OptiMedica for up to $400 million and in a separate deal would pay $310...

News

Valeant Pharma Near Deal to Acquire Bausch & Lomb

24.05.2013 - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb from private equity owner Warburg Pincus for about $9 billion, a person...

News

Obagi Medical Gets Higher Offer from Merz Pharma

02.04.2013 - Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...

News

Sanofi Won't Go Above $70 per Share for Genzyme

26.08.2010 - Sanofi-Aventis is not willing to pay more than $70 per share for U.S. biotech Genzyme and may look at alternative targets, Bloomberg reported on Wednesday, citing sources familiar...